SHANG.FOS.PHARM.GR.H YC 1 (08HH) — Free Cash Flow Generation Index
SHANG.FOS.PHARM.GR.H YC 1 (08HH) has a Free Cash Flow Generation Index of 0.15x as of December 2025. Free cash flow of €764.78 Million represents 0% of operating cash flow (€5.21 Billion). Explore capital reinvestment ratio of SHANG.FOS.PHARM.GR.H YC 1 to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SHANG.FOS.PHARM.GR.H YC 1 Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for SHANG.FOS.PHARM.GR.H YC 1 across 5 annual periods. For the full cash flow conversion analysis, see SHANG.FOS.PHARM.GR.H YC 1 cash conversion from operations.
Annual Free Cash Flow Generation for SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)
Year-by-year Free Cash Flow Generation Index for SHANG.FOS.PHARM.GR.H YC 1. Check total reinvestment intensity of SHANG.FOS.PHARM.GR.H YC 1 to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.15x | €764.78 Million | €5.21 Billion | €4.45 Billion | ▲ +883.3% |
| 2024 | 0.01x | €66.79 Million | €4.48 Billion | €4.41 Billion | ▲ +102.6% |
| 2023 | -0.56x | €-1.92 Billion | €3.41 Billion | €5.34 Billion | ▼ -42.1% |
| 2022 | -0.40x | €-1.67 Billion | €4.22 Billion | €5.89 Billion | ▼ -50.8% |
| 2021 | -0.26x | €-1.03 Billion | €3.94 Billion | €4.97 Billion | — |